Webinar

Webinars

 
MiniMed Insulin Pump Therapy: Driving Outcomes for Type 2 Patients
Dr. Vigersky explains how insulin pump therapy can improve both glucose control and quality of life for patients with type 2 diabetes.

Robert Vigersky, M.D. Medical Director

MiniMed 670G System with SmartGuard HCL Technology

MiniMed<sup>™</sup> 670G System


Indicated for type 1 patients 14 and over. Requires a prescription. WARNING: May not be safe for those under 7 or those requiring less than 8 units of insulin per day.

MiniMed 670G System Education Videos
Gain a deeper understanding of the study results, key features and new CareLink software reports.

MiniMed® 670G System



Indicated for type 1 patients 14 and over. Requires a prescription. WARNING: May not be safe for those under 7 or those requiring less than 8 units of insulin per day.

Webinar Presentation with Francine R. Kaufman, M.D
Chief Medical Officer and VP of Global Clinical, Medical and Health Affairs

MiniMed® 670G System with Guardian® Sensor 3
Take a closer look at the world’s first hybrid closed loop system with Dr. Fran Kaufman.

Webinar Presentation with Francine R. Kaufman, M.D
Chief Medical Officer and VP of Global Clinical, Medical and Health Affairs

MiniMed® 630G System
Dr. Fran Kaufman introduces the MiniMed 630G system.

Video Presentation with Timothy R. Gilbert, M.D.
Endocrinologist at Imperial Health

Implementing MiniMed® 530G with Enlite Best Practices and Training
Hear from Dr. Timothy R. Gilbert on setting up practice management goals, performing practice efficiency as a team, and best practices in implementing Threshold Suspend technology that you can begin incorporating in your office today!

Video Presentation with Paul Wadwa, M.D.
Barbara Davis Center for Diabetes

Utilizing CareLink® with New Teleconferencing Technologies
Dr. Wadwa discusses the use of CareLink® with telemedicine and reviews a case study examining telemedicine's role in the care of type 1 diabetes (T1D).

Video Presentation with Bruce Bode, MD, FACE
OpT2mise investigator, Atlanta Diabetes Associates

Insulin Pump Therapy: An Effective Treatment Option for Type 2 Diabetes
Dr. Bode will review the study design and results of the OpT2mise trial and present an informative case study on one of the patients who participated in the study.

Video Presentation with Francine R. Kaufman, M.D.
Chief Medical Officer and Vice President, Global Medical, Clinical Health Affairs

MiniMed® 530G with Enlite® Clinical Evidence
Dr. Kaufman presents clinical evidence for the problem of hypoglycemia and the evidence that the MiniMed 530G system helps ameliorate this problem both in clinical trials and in real-world use.

Webinar with Francine R. Kaufman, M.D.
Chief Medical Officer and Vice President, Global Medical, Clinical Health Affiars

Interpreting CareLink Pro Data
Using Continuous Glucose Monitoring and Insulin Pump Therapy to Fine-Tune Glycemic Control: A Case-Based Approach

Webinar with Rajiv Shah
VP, Continuous Glucose Monitoring R&D and Operations at Medtronic Diabetes

Enlite Sensor Technology Update
by Rajiv Shah VP, Continuous Glucose Monitoring R&D and Operations at Medtronic Diabetes Webinar featuring insights on Enlite sensor innovations, Enlite performance, Enlite Calibration, and Enlite taping tips.

Play All Videos

Webinar with Satish K. Garg, M.D.
Professor of Medicine and Pediatrics, Barbara Davis Center for Diabetes, University of Colorado Denver, USA. Editor-in-Chief, Diabetes Technology & Therapeutics

Satish K. Garg, M.D.
Artificial Pancreas Technology Webinar
Explore ways to implement the artificial pancreas technology through a real life case study.

Webinar with Francine R. Kaufman, M.D.
Chief Medical Officer and Vice President, Global Medical, Clinical Health Affairs

A clinical review of MiniMed® 530G with Enlite®
The First FDA Approved Artificial Pancreas Device with Threshold Suspend: A clinical review of MiniMed 530G with Enlite, with Francine R. Kaufman, M.D.

Webinar with Thomas Blevins, MD
Founder, Texas Diabetes and Endocrinology in Austin, TX

Insulin Pump Therapy: A Review of Scientific Evidence
Take a closer look at the scientific evidence behind 30 years of diabetes technology development with Dr. Thomas Blevins, founder of Texas Diabetes and Endocrinology. This informative Webinar provides a detailed medical review of diabetes management clinical evidence, from the ability of Intensive Insulin Therapy to reduce long-term complications to the comparative effectiveness of Insulin Pump Therapy versus Multiple Daily Injections (MDI). Dr. Blevins not only explains why Pump Therapy is potentially more effective, he guides you through many of the processes associated with incorporating Pump Therapy into your practice.

Play All Videos

Webinar with Steven D. Wittlin, MD
Professor of Medicine, University of Rochester School of Medicine and Dentistry

Steven D. Wittlin, MD
Insulin Pump Therapy in Type 2 Diabetes
Learn how your patients with type 2 diabetes can benefit from insulin pump therapy through a webinar with Dr. Steven D. Wittlin.

Dr. Timothy Gilbert is a Clinical Endocrinologist with over 10 years of experience in the complex management of patients with Type I and Type II Diabetes. He received his Doctorate of Medicine from Louisiana State University Health Sciences Center in New Orleans, Louisiana. He completed a residency in Internal Medicine at LSU Health Science Center in Baton Rouge, Louisiana, followed by an Endocrinology and Metabolic Disease fellowship at Ochsner Health Systems in New Orleans, Louisiana.

Dr. Gilbert places a strong emphasis on the aggressive management of diabetes, including achieving and maintaining glycemic control from the onset of the disease. Dr. Gilbert has a vast amount of experience with intensive insulin management including utilization of injectable insulin, inhaled insulin and utilization of insulin pump / continuous glucose sensing technology. The practice presently manages over 500 active insulin pump patients. Dr. Gilbert practices Endocrinology and Metabolic Disease at the Endocrinology Center of Southwest Louisiana where he is both founder and medical director. The practice is located in Lake Charles, Louisiana, and is a division of Imperial Health (Southwest/Southcentral Louisiana’s largest physician owned multispecialty group). The practice houses an AADE Certified Diabetes Education Center and has been previously recognized as a center of excellence in diabetes technology by Medtronic Diabetes.

Dr. Gilbert is considered a leader in the field of diabetes management, serving as both a consultant and a speaker on a national level for numerous healthcare and pharmaceutical companies. In addition, he has served as a primary investigator and sub-investigator on several studies, including some of the early inhaled insulin research. He is a member of the American Association of Clinical Endocrinologist, American Diabetes Association-Professional Section, The Endocrine Society and the Louisiana State Medical Society. He serves as a parish delegate for the medical society on the state level and also serves as the director of several endocrine and diabetes programs throughout Southwest Louisiana. He is on the Board of Directors and chairman elect (2016-2018) for Imperial Health. He also serves on the following committees for Imperial Health: recruitment committee, business development committee, and the operations and standardization committee.

Dr. Gilbert speaks frequently on a regional and national level. In the past year, he has presented over 100 promotional and CME activities across the country, including national events such as the American Diabetes Association annual meeting in Boston and the American Association of Diabetes Educators national meeting in New Orleans. He is also a regular presenter for Medtronic Diabetes at their headquarters in Los Angeles, California, where attendees from around the world attend symposiums on insulin pump and continuous glucose sensing therapy.
Dr. Paul Wadwa is an Associate Professor of Pediatrics at the University of Colorado School of Medicine. He has been on faculty at the Barbara Davis Center for Diabetes since 2003.

Due to his extensive knowledge on telemedicine, Dr. Wadwa has presented on this subject at prominent diabetic conferences such as the Practical Ways to Achieve Targets in Diabetes Care (ATDC) Keystone Conference and American Association of Diabetes Educators (AADE). Clinically, Dr. Wadwa is the Director of Telemedicine at the Barbara Davis Center.

Dr. Wadwa graduated from Northwestern University Feinberg School of Medicine. He completed residency in Pediatrics and served as a chief resident at Nationwide Children’s Hospital in Columbus, Ohio and completed a fellowship in pediatric endocrinology at Cincinnati Children’s Hospital Medical Center.
Dr. Bode is a diabetes specialist with Atlanta Diabetes Associates in Atlanta, Georgia, and is currently on the faculty of Emory University, as a Clinical Associate Professor in the Department of Medicine.

He received his medical degree from Emory University School of Medicine and completed an internship and residency in internal medicine at Emory University Affiliated Hospitals and a fellowship in diabetes with Paul C. Davidson, MD.

He has a strong affinity for working with children and young adults with diabetes and is considered one of the leading experts in the world on insulin delivery and glucose sensing. He is very active in clinical research on new diabetes products including pharmacological agents to prevent diabetes and control glucose and new insulins and glucose sensors.

He is a prolific writer with over 200 articles and books in the field of diabetes discussing current and future therapies for people with diabetes. He also sits on the advisory board of many of the leading companies in the field of diabetes care and research including the Juvenile Diabetes Research Foundation, the American Diabetes Association (ADA), and the Georgia diabetes camps.
Dr. Bode is a diabetes specialist with Atlanta Diabetes Associates in Atlanta, Georgia, and is currently on the faculty of Emory University, as a Clinical Associate Professor in the Department of Medicine.

He received his medical degree from Emory University School of Medicine and completed an internship and residency in internal medicine at Emory University Affiliated Hospitals and a fellowship in diabetes with Paul C. Davidson, MD.

He has a strong affinity for working with children and young adults with diabetes and is considered one of the leading experts in the world on insulin delivery and glucose sensing. He is very active in clinical research on new diabetes products including pharmacological agents to prevent diabetes and control glucose and new insulins and glucose sensors.

He is a prolific writer with over 200 articles and books in the field of diabetes discussing current and future therapies for people with diabetes. He also sits on the advisory board of many of the leading companies in the field of diabetes care and research including the Juvenile Diabetes Research Foundation, the American Diabetes Association (ADA), and the Georgia diabetes camps.
Francine Ratner Kaufman, M.D. was director of the Comprehensive Childhood Diabetes Center, and head of the Center for Endocrinology, Diabetes and Metabolism at Childrens Hospital Los Angeles until 2009 when she stepped down to become Chief Medical Officer and VP of Global Clinical, Medical and Health affairs at Medtronic Diabetes (Northridge, CA). Dr. Kaufman is Distinguished Professor Emerita of Pediatrics and Communications at the Keck School of Medicine and the Annenberg School of Communications of the University of Southern California, and an attending physician at Childrens Hospital Los Angeles. Dr. Kaufman has published more than 220 peer-reviewed and invited publications. She is the author of more than 40 books or book chapters. In 2012, she authored the Insulin Pump and Glucose Sensor Book for the ADA and edited the 6th edition of the ADA’s the Medical Management of Type 1 Diabetes. In 2005 her book, Diabesity, was published by Bantam. Dr. Kaufman was chair of the National Institutes of Health funded Studies to Treat (the TODAY Trial) and Prevent (the HEALTHY Trail) Type 2 Diabetes in Youth (DTOPP-T2). She was a principal investigator of TrialNet, a multinational consortium evaluating ways to prevent type 1 diabetes, funded by the NIH. She was instrumental in banning sodas from Los Angeles Unified School District in 2003.

Dr, Kaufman was notional president of the American Diabetes Association in 2002-03. She was elected to AOA Medical Honorary Society. She was president of Shaping America’s Health, Consultative Section of the International Diabetes Federation. In 2007, she was Co-Chair of the diabetes treatment and prevention strategies for the Medicaid population. In 2005, she was elected Membership in the Institute of Medicine. In 2007, Dr. Kaufman filmed a documentary for Discovery Health on the global diabetes epidemic that was aired around the world on World Diabetes Day, November 14, 2007. In 2009, she was elected to membership in the Advisory Council of the Diabetes Branch of the NIH.
Rajiv Shah is Vice President, Continuous Glucose Monitoring R&D and Operations at Medtronic Diabetes. Mr. Shah is a renowned sensor expert in diabetes technology and holds 36 U.S. patents. He has worked at MiniMed and Medtronic for 28 years in various positions of scientifi c and engineering leadership. In 2005, Rajiv received the Bakken Award from Medtronic Inc. for his scientifi c and research contributions in the fi eld of diabetes. Before joining Medtronic, Mr. Shah was a Director, Sensor Chemical Engineering for Medical Research Group (MRG) focusing on the world’s fi rst long-term implantable glucose sensor. Mr. Shah received his master’s degree in chemical engineering from UCLA.
Thomas Blevins is an adult endocrinologist at Texas Diabetes & Endocrinology in Austin, TX. He leads a staff of endocrinologists, physician assistants, clinical nurse specialists, and Certified Diabetes Educators who are devoted to diabetes management. Educating people about their condition is a priority throughout the practice. Dr. Thomas Blevins attended medical school at the Baylor College of Medicine in Houston and completed his internal medicine and endocrinology training there as well. He has been in Austin since 1986 and was with the Austin Diagnostic Clinic until 2001 when he founded Texas Diabetes and Endocrinology, a practice devoted to bringing the latest in diabetes advances, thyroid care and osteoporosis diagnostics and treatment to Austin and Central Texas. He is active in clinical research concerning endocrine diseases and is a national level speaker and educator for a number of topics in the areas of diabetes, osteoporosis, lipid management, and thyroid disease.